Abstract
Besides the widespread use of hormones for contraception, pure estrogens are given to relieve menopausal symptoms and progestogens are prescribed for the treatment of endometriosis and endometrial carcinoma. In recent years this has provided opportunities for studying certain structural differentiations which emerge during the process of carcinogenesis in the cervix. These observations are based on prolonged study of the different effects of estrogens and progestogens on the squamous epithelium of the ectocervix and the mucosa of the endocervical canal. Estrogens stimulate proliferation of the stratified squamous epithelium of the ectocervix, but not that of the columnar epithelium of the endocervix. Progestogens stimulate the columnar epithelium and the reserve cells beneath it,’but not the squamous epithelium. When an epithelial defect develops on the external surface of the cervix because of erosion of the vulnerable columnar epithelium that has grown out at that site as the result of ectopia, under estrogenic stimulation it becomes reepithelialized mainly by the stratified squamous epithelium: the defect is covered by regenerative epithelium (Fig. 1), which grows over it from outside and spreads upward, i.e., from the external surface into the cervical canal. Under conditions of progestogenic stimulation, on the other hand, proliferation of the reserve cells of the cervical mucosa in the form of reserve cell hyperplasia (Fig. 2) often precedes regeneration of the squamous epithelium.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Boddington MM, Spriggs AI, Cowdell R (1976) Adenocarcinoma of the uterine cervix: cytological evidence of a long preclinical evolution. Brit J Obstet Gynaec 83:900
Büttner HH, Kyank H (1973) Adenocarcinoma in situ der Cervix uteri nach 11 Jahren gefolgt von invasivem Adenocarcinom. Z Krebsforsch 80:197
Burghardt E (1966) Das Adenocarcinoma in situ der Cervix. Arch Gynäk 203:57
Candy, Abell MR (1968) Progestogen-induced adenomatous hyperplasia of the uterine cervix. JAMA 2023:323
Carter B, Thomas WL, Parker RT (1949) Adenocarcinoma of the cervix and of the cervical stump. Am J Obstet Gynaec 57:37–5
Christopherson WM, Nealon N, Gray LA (1979) Noninvasive precursor lesions of adenocarcinoma and mixed adenosquamous carcinoma of the cervix uteri. Cancer 44:975
Czernobilsky B, Kessler I, Lancet M (1974) Cervical adenocarcinoma in a woman on long-term contraceptives. Obstet Gynec 43:517
Dallenbach-Hellweg G (1972) Therapieschäden in der Gynäkologie. Morphologische Beobachtungen über die Auswirkungen weiblicher Sexualhormone und von Stoffen mit ähnlicher Wirkung. Verh Dtsch Ges Path 56:252
Davis JR, Moon LB (1975) Increased incidence of adenocarcinoma of uterine cervix. Obstet Gynec 45:79
Friedell GH, McKay DG (1953) Adenocarcinoma in situ of the endocervix. Cancer 6:887
Gall SA, Bourgeois CH, Maguire G (1969) The morphologic effects of oral contraceptive agents on the cervix. JAMA 207:2243
Gallup DG, Abell MR (1977) Invasive adenocarcinoma of the uterine cervix. Obstet Gynec 49:596
Hamperl H (1965) Vor- und Frühstadien des Portio-Carcinoms. Geburtsh u Frauen-heilk 25:105
Hellweg G (1957) Über Schleimbildung in Plattenepithelcarcinomen, insbesondere an der Portio uteri (Mucoepidermoidcarcinome). Z Krebsforsch 61:688–715
Krimmenau R (1966) Adenocarcinoma in situ, beginnende adeno-carcinomatöse Invasion und Microcarcinoma adenomatosum. Geburtsh u Frauenheilk 26:1297
Kyriakos M, Kempson RL, Konikov NF (1968) A clinical and pathologic study of endocervical lesions associated with oral contraceptives. Cancer 22:99
Lauchlan SC, Penner DW (1967) Simultaneous adenocarcinoma in situ and epidermoid carcinoma in situ: report of 2 cases. Cancer 20:2250–2254
Maqueo M, Azuela JC, Calderón JJ, Goldzieher HW (1966) Morphology of the cervix in women treated with synthetic progestins. Am J Obstet Gynec 96:994
Mingeot R, Fievez CI (1974) Endocervical changes with the use of synthetic steroids. Obstet Gynec 44:53
Nichols TM, Fidler HK (1971) Microglandular hyperplasia in cervical cone biopsies taken for suspicious and positive cytology. Am J Clin Path 56:424–429
Qizilbash AH (1975) In-situ and microinvasive adenocarcinoma of the uterine cervix. Am J Clin Path 64:155–170
Sachs H, Würthner K (1972) Zytologische, histologische und zytofotometrische Befunde eines Adenocarcinoma in situ der Cervix uteri. Geburtsh u Frauenheilk 32: 846
Talbert JR, Sherry JB (1969) Adenocarcinoma-like lesion of cervix, a “ttpill-induced” problem? Am J Obstet Gynec 105:117
Taylor HB, Irey NS, Norris HJ (1967) Atypical endocervical hyperplasia in women taking oral contraceptives. JAMA 202:637–639
Weisbrot IM, Stabinsky C, Davis AM (1972) Adenocarcinoma in situ of the uterine cervix. Cancer 29:1179
Werner R, Dinges HP (1976) Über durch Ovulationshemmer verursachte spezifische Veränderungen der Cervix uteri. Zbl Gynäk 98:919
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Dallenbach-Hellweg, G. (1981). Structural Variations of Cervical Cancer and Its Precursors Under the Influence of Exogenous Hormones. In: Dallenbach-Hellweg, G. (eds) Cervical Cancer. Current Topics in Pathology, vol 70. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-68185-1_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-68185-1_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-68187-5
Online ISBN: 978-3-642-68185-1
eBook Packages: Springer Book Archive